Cite
Atovaquone-Proguanil Remains a Potential Stopgap Therapy for Multidrug-Resistant Plasmodium falciparum in Areas along the Thai-Cambodian Border
MLA
Chanthap Lon, et al. “Atovaquone-Proguanil Remains a Potential Stopgap Therapy for Multidrug-Resistant Plasmodium Falciparum in Areas along the Thai-Cambodian Border.” Antimicrobial Agents and Chemotherapy, vol. 60, Mar. 2016, pp. 1896–98. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....39dcc1f8df8afd7594bb5a9b936534c5&authtype=sso&custid=ns315887.
APA
Chanthap Lon, Suwanna Chaorattanakawee, Satharath Prom, Panita Gosi, Sok Somethy, Worachet Kuntawunginn, Charlotte A. Lanteri, David L. Saunders, Soklyda Chann, Michele D. Spring, Carrie Gregory, Char Meng Chuor, & Mali Ittiverakul. (2016). Atovaquone-Proguanil Remains a Potential Stopgap Therapy for Multidrug-Resistant Plasmodium falciparum in Areas along the Thai-Cambodian Border. Antimicrobial Agents and Chemotherapy, 60, 1896–1898.
Chicago
Chanthap Lon, Suwanna Chaorattanakawee, Satharath Prom, Panita Gosi, Sok Somethy, Worachet Kuntawunginn, Charlotte A. Lanteri, et al. 2016. “Atovaquone-Proguanil Remains a Potential Stopgap Therapy for Multidrug-Resistant Plasmodium Falciparum in Areas along the Thai-Cambodian Border.” Antimicrobial Agents and Chemotherapy 60 (March): 1896–98. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....39dcc1f8df8afd7594bb5a9b936534c5&authtype=sso&custid=ns315887.